HOME >> MEDICINE >> NEWS
UK and other European countries should introduce universal childhood hepatitis B vaccination

most effective means of reducing the global burden of a particular disease. It also protects children before they are at risk of infection, and vaccines available today can immunise individuals for life with no need for additional booster vaccinations. Disadvantages include cost-effectiveness in countries of low endemicity and concerns about adding another vaccine into the childhood vaccination programme.

The advantages of the at-risk strategy are that an immediate impact within the target group can be obtained, with low cost in countries with low endemicity. Disadvantages include leaving the general population at risk, the difficulties in properly identifying at risk groups and the social stigma of being defined at-risk.

The authors conclude that on the basis of current experience and evidence, the UK, Ireland, Finland, Iceland, the Netherlands, Norway, Sweden, and Denmark should all adopt a universal vaccination policy.

They say: Global hepatitis B universal vaccination is ultimately the only way to eliminate HBV transmission and new cases of hepatitis B. Indeed, global efforts to control and prevent hepatitis B are of crucial importance and it is the responsibility of each country worldwide to play its part.


'"/>

Contact: Dr. Jane Zuckerman
j.zuckerman@medsch.ucl.ac.uk
44-779-887-6445
Lancet
5-Jun-2007


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
3. Borderline personality disorder shows improvements with intensive psychotherapy
4. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
5. Chemotherapy may enhance the effectiveness of brain tumor vaccines
6. Brain-boosting pill alleviates post-chemotherapy fogginess
7. Adding radioimmunotherapy to chemo may help patients with lymphoma
8. Pre-operative chemotherapy does not increase survival rates for nonsmall cell lung cancer
9. Medical management of another condition may not lead to early cancer diagnosis
10. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
11. New mothers often not asked about depression, UNC survey finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... ... November 30, 2016 , ... ... clinical research community that the FDA Binding Guidance goes into effect next month. ... formats listed in the FDA Data Standards Catalog. The current FDA Data Standards ...
(Date:11/30/2016)... ... November 30, 2016 , ... U.S. Security Associates (USA) ... services based in Richmond, Virginia. The acquisition further strengthens USA’s capabilities within ... security services and prides itself on 100% client-retention to the healthcare industry. In ...
(Date:11/30/2016)... Philadelphia, PA (PRWEB) , ... November 30, 2016 ... ... and pharmaceutical organizations to build intelligent, connected applications, announces today that it has ... (HITRUST). , CloudMine, has been self-certified as compliant with the HITRUST CSF ...
(Date:11/30/2016)... ... November 30, 2016 , ... Staying on top ... deductibles, more restrictive lists of healthcare providers and soaring drug costs. To help ... estimator tools, offered by New York health plans. These tools, which are ...
(Date:11/30/2016)... Linda, Ca (PRWEB) , ... November 30, 2016 , ... ... in Best in Biz Awards, the only independent business awards program judged by members ... progress as it drives revenue and growth, while maintaining partner relations. In 2015 LabRoots ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 CVS Health ... annual Analyst Day in New York City on Thursday, December 15, 2016, ... Health leadership team will provide an in-depth review of ... shareholder value. The company will also discuss 2017 earnings ... video webcast of the event will be broadcast simultaneously ...
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... Extremity Braces & Support) is Expected to Gain a Significant ... Prone to Orthopedic Ailments  ... , , According ... Market Study on Medical Implants Sterile Packaging: Clamshell Product Type ...
(Date:12/2/2016)...   CytoSorbents Corporation (NASDAQ: CTSO ), ... approved CytoSorb ® cytokine adsorber to treat deadly ... that Dr. Phillip Chan , Chief Executive Officer, ... Main Event investor conference held from December 6 ... Boulevard Hotel in Los Angeles, California ...
Breaking Medicine Technology:
Cached News: